Navigation Links
Elsevier announces 2008 journal impact factor highlights
Date:6/29/2009

Amsterdam, 29 June 2009 Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the highlights of its journal impact factor performance in 2008. Elsevier overall saw 75% of its journal impact factors (IF) increase from 2007 to 2008. According to the 2008 Journal Citation Report published by ThomsonReuters, Elsevier journals took the #1 position in 51 categories (of 229 in total) across all of the sciences and social sciences.

In addition, 30 Elsevier journals got their first IF this year. Some of these journals received very impressive scores including two Cell Press journals: Cell Stem Cell (http://www.cell.com/cell-stem-cell/home) (16.826) entered the Cell Biology category ranked 6th (of 157 journals), while Cell Host & Microbe (http://www.cell.com/cell-host-microbe/home) (7.436) entered the Microbiology category ranked10th (of 91 journals). Another impressive result in its first year is Materials Today (http://www.materialstoday.com/) (12.929), which is ranked 4th in the Materials Science, Multidisciplinary category (of 191 journals).

This year there were 182 Elsevier journals that increased their IF by more than 50% over their 2007 scores. All three The Lancet speciality journals improved their IF this year. The Lancet Infectious Diseases (http://www.thelancet.com/journals/laninf/issue/current) increased to 13.165, placing it at the #1 position in the Infectious Diseases category. The Lancet Oncology (http://www.thelancet.com/journals/lanonc/issue/current) rose to 13.283, an increase of over 1 full IF point from the 2007 IF. Finally, The Lancet Neurology (http://www.thelancet.com/journals/laneur/issue/current) increased by 40% to 14.270, thereby retaining the #1 position in the Clinical Neurology category for the 5th year running.

Other Elsevier journals continue their long-running trend of increased IFs, in particular Biomaterials (http://www.elsevier.com/locate/biomaterials) (increasing yearly since 2003) and The Journal of Allergy and Clinical Immunology (http://www.elsevier.com/locate/jaci) which has shown consistent growth over the past five years.

Glen Campbell, Senior Vice President of U.S. Health Sciences Journals said, "Each annual announcement of impact factors confirms the depth and excellence of our health sciences journal publishing program. The superior performance of so many of our journals this year is a sign of the strong partnerships we have with our journal editors and our societies. This year's impact factor growth is one indication of the hard work and focus on quality of these collaborations."

"The fact that Elsevier's overall results are amongst the best in the industry is a true indication of the impact of the increased focus on quality we have placed on our journals in the past three years. The increased impact factors, across the board, are evidence that the research we publish is of the highest quality," remarked Martin Tanke, Managing Director of Science and Technology Journals. "We are grateful for our strong network of editors we partner with, who work with us each day to build our journals to some of the best in their fields."

The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year. The impact factor helps to evaluate a journal's relative importance, especially when compared with others in the same field.


'/>"/>

Contact: Shira Tabachnikoff
s.tabachnikoff@elsevier.com
31-204-852-736
Elsevier
Source:Eurekalert

Related biology news :

1. Institution of Chemical Engineers chooses Elsevier as publishing partner
2. Elsevier announces new journal partnership for 2008
3. Elsevier launches new journal: Journal of Natural Gas Science and Engineering
4. Elsevier launches Bioscience Hypotheses
5. Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge
6. Elsevier congratulates its British Medical Association Award winning medical authors and editors
7. Elsevier partners with the Royal Netherlands Society for Agricultural Sciences
8. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
9. Finalists announced in the Elsevier Grand Challenge
10. Winners announced in the Elsevier Grand Challenge
11. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the world-leading ... and publication industries, will provide the data management solution ... (NPSC). ... Phenotypic analysis measures the ... organisms, allowing comparisons between states such as health and ...
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/15/2016)... Puerto Rico , Jan. 15, 2016 ... big and small to find new ways to ensure ... culture. iOS and Android ... based on biometrics, transforming it into a hardware authorization ... that users swipe their fingerprint on their KodeKey enabled ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... ... 09, 2016 , ... Creation Technologies, leading global provider of ... Customer Rating Award from Circuits Assembly , today announced its milestone achievement of ... Mexico and China. , The EMS provider, known in the EMS industry for ...
(Date:2/9/2016)... ... February 08, 2016 , ... Date and time: ... Institute at the Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, ... College (TCMC) will hold an open house for participants to learn about a ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Tunnell Consulting, ... Based in Paris, he will focus on acquiring new accounts and work closely ... , “Fred brings to our European clients more than 15 years ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove announced ... the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to ... heard throughout the drug regulatory review process. , “Adding Diane Dorman is just ...
Breaking Biology Technology: